EBITDA Summary of Boiron SA

Boiron SA's latest annual EBITDA in 2023 was 80.67 Million EUR , down -25.51% from previous year.
Boiron SA's latest quarterly EBITDA in 2024 Q2 was 22.73 Million EUR , down 0.0% from previous quarter.
Boiron SA reported an annual EBITDA of 91.33 Million EUR in 2022, up 23.81% from previous year.
Boiron SA reported an annual EBITDA of 78.75 Million EUR in 2021, down -29.96% from previous year.
Boiron SA reported a quarterly EBITDA of 28.35 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Boiron SA reported a quarterly EBITDA of 34.23 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Boiron SA (2023 - 2001)

Historical Annual EBITDA of Boiron SA (2023 - 2001)

Year	EBITDA	EBITDA Growth
2023	80.67 Million EUR	-25.51%
2022	91.33 Million EUR	23.81%
2021	78.75 Million EUR	-29.96%
2020	68.9 Million EUR	-6.53%
2019	99.15 Million EUR	-22.71%
2018	138.56 Million EUR	-12.21%
2017	159.37 Million EUR	-1.69%
2016	157 Million EUR	-0.42%
2015	150.9 Million EUR	-5.7%
2014	167.73 Million EUR	-0.88%
2013	156.4 Million EUR	49.73%
2012	117.17 Million EUR	34.37%
2011	86.57 Million EUR	-15.23%
2010	87.57 Million EUR	-7.9%
2009	110.87 Million EUR	29.86%
2008	81.51 Million EUR	35.91%
2007	63.03 Million EUR	67.05%
2006	38 Million EUR	-23.51%
2005	49 Million EUR	1.04%
2004	48.45 Million EUR	-14.16%
2003	56.68 Million EUR	10.11%
2002	51.48 Million EUR	19.89%
2001	42.94 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	22.73 Million EUR	0.0%
2023 Q2	28.35 Million EUR	0.0%
2023 Q4	34.23 Million EUR	0.0%
2023 FY	- EUR	-25.51%
2022 Q2	32.67 Million EUR	0.0%
2022 Q4	54.4 Million EUR	0.0%
2022 FY	- EUR	23.81%
2021 FY	- EUR	-29.96%
2021 Q4	67.12 Million EUR	0.0%
2021 Q2	3.67 Million EUR	0.0%
2020 Q2	45.7 Million EUR	0.0%
2020 Q4	55.37 Million EUR	0.0%
2020 FY	- EUR	-6.53%
2019 FY	- EUR	-22.71%
2019 Q4	78.93 Million EUR	0.0%
2019 Q2	27.17 Million EUR	0.0%
2018 Q2	48.98 Million EUR	0.0%
2018 FY	- EUR	-12.21%
2018 Q4	90.93 Million EUR	0.0%
2017 Q2	57.18 Million EUR	0.0%
2017 Q4	102.19 Million EUR	0.0%
2017 FY	- EUR	-1.69%
2016 FY	- EUR	-0.42%
2016 Q2	60.67 Million EUR	0.0%
2016 Q4	101.44 Million EUR	0.0%
2015 Q4	106.57 Million EUR	0.0%
2015 Q2	56.21 Million EUR	0.0%
2015 FY	- EUR	-5.7%
2014 Q2	51.49 Million EUR	0.0%
2014 FY	- EUR	-0.88%
2014 Q4	121.14 Million EUR	0.0%
2013 Q2	59.95 Million EUR	0.0%
2013 FY	- EUR	49.73%
2013 Q4	114.21 Million EUR	0.0%
2012 Q2	29.29 Million EUR	0.0%
2012 FY	- EUR	34.37%
2012 Q1	29.29 Million EUR	0.0%
2012 Q3	29.29 Million EUR	0.0%
2012 Q4	41.22 Million EUR	40.72%
2011 Q2	21.64 Million EUR	0.0%
2011 FY	- EUR	-15.23%
2011 Q4	29.29 Million EUR	35.36%
2011 Q1	21.64 Million EUR	0.0%
2011 Q3	21.64 Million EUR	0.0%
2010 Q2	25.59 Million EUR	0.0%
2010 FY	- EUR	-7.9%
2010 Q4	21.64 Million EUR	-15.44%
2010 Q3	25.59 Million EUR	0.0%
2010 Q1	25.59 Million EUR	0.0%
2009 Q2	27.56 Million EUR	0.0%
2009 Q3	27.56 Million EUR	0.0%
2009 Q4	25.59 Million EUR	-7.15%
2009 FY	- EUR	29.86%
2009 Q1	27.56 Million EUR	0.0%
2008 FY	- EUR	35.91%
2008 Q4	27.56 Million EUR	29.15%
2008 Q3	21.34 Million EUR	0.0%
2008 Q2	21.34 Million EUR	0.0%
2008 Q1	21.34 Million EUR	0.0%
2007 Q3	15.7 Million EUR	0.0%
2007 Q2	15.7 Million EUR	0.0%
2007 Q1	15.7 Million EUR	0.0%
2007 Q4	21.34 Million EUR	35.91%
2007 FY	- EUR	67.05%
2006 Q4	15.7 Million EUR	65.4%
2006 Q3	9.49 Million EUR	0.0%
2006 Q2	9.49 Million EUR	0.0%
2006 Q1	9.49 Million EUR	0.0%
2006 FY	- EUR	-23.51%
2005 FY	- EUR	1.04%
2005 Q4	9.49 Million EUR	-22.5%
2005 Q3	12.25 Million EUR	0.0%
2005 Q2	12.25 Million EUR	0.0%
2005 Q1	12.25 Million EUR	0.0%
2004 FY	- EUR	-14.16%
2004 Q4	12.25 Million EUR	1.18%
2004 Q3	12.1 Million EUR	0.0%
2004 Q2	12.1 Million EUR	0.0%
2004 Q1	12.1 Million EUR	0.0%
2003 Q4	12.1 Million EUR	13.18%
2003 FY	- EUR	10.11%
2003 Q3	10.69 Million EUR	0.0%
2003 Q2	10.69 Million EUR	0.0%
2003 Q1	10.69 Million EUR	0.0%
2002 Q1	9.41 Million EUR	0.0%
2002 FY	- EUR	19.89%
2002 Q4	10.69 Million EUR	13.64%
2002 Q3	9.41 Million EUR	0.0%
2002 Q2	9.41 Million EUR	0.0%
2001 FY	- EUR	0.0%
2001 Q1	7.54 Million EUR	0.0%
2001 Q2	7.54 Million EUR	0.0%
2001 Q3	7.54 Million EUR	0.0%
2001 Q4	9.41 Million EUR	24.77%
2000 Q4	7.54 Million EUR	0.0%

Peer EBITDA Comparison of Boiron SA

Name	EBITDA	EBITDA Difference
Laboratorios Farmaceuticos Rovi, S.A.	238.01 Million EUR	66.104%
Vetoquinol SA	104.58 Million EUR	22.855%
Valneva SE	-64.51 Million EUR	225.051%
AB Science S.A.	-9.28 Million EUR	969.292%
Nanobiotix S.A.	-34.01 Million EUR	337.159%
PHAXIAM Therapeutics S.A.	-22.93 Million EUR	451.849%
Vivoryon Therapeutics N.V.	-28.35 Million EUR	384.552%
BioSenic S.A.	-6.79 Million EUR	1287.154%
ABIVAX Société Anonyme	-133.2 Million EUR	160.567%
Formycon AG	81.05 Million EUR	0.461%

Global Stocks Search

Boiron SA (0DTF.L)

EBITDA Summary of Boiron SA

Annual EBITDA Chart of Boiron SA (2023 - 2001)

Historical Annual EBITDA of Boiron SA (2023 - 2001)

Peer EBITDA Comparison of Boiron SA